Main menu
Edison Group
  • Home
  • Sparks
  • Equities

    Equities

    View All Equities

    Equities by Sector

    OpGen

    MCap

    USD50m

    Last close

    USD4.00

    ▲ 1.03 (34.68%)

    The Metals Company

    MCap

    USD2,114m

    Last close

    USD4.79

    ▲ 0.82 (20.65%)

    Metals One

    MCap

    —

    Last close

    GBP0.01

    ▲ 0.18 (19.44%)

  • Sectors

    Sectors

  • Megatrends

    Megatrends

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Oryzon Genomics – equity proposition

Oryzon Genomics – equity proposition

Oryzon Genomics — 8 videos in collection

More on this equity

Oryzon Genomics is a clinical-stage biotechnology company focused on the development of epigenetic therapies, targeting gene regulation mechanisms implicated in cancer and central nervous system (CNS) disorders. Its two lead assets, iadademstat and vafidemstat, are designed to address areas of high unmet need across oncology-haematology and neuropsychiatric conditions, respectively. The company is advancing both programmes through clinical development, supported by a growing body of data and a series of upcoming milestones.

We highlight the key points of Oryzon Genomics’s investment story.

  1. Iadademstat presents a differentiated opportunity in haematological diseases.
  2. A dense pipeline of near-term catalysts may drive investor attention.
  3. Vafidemstat offers longer-term upside in CNS indications.
  4. A diversified pipeline and dual therapeutic focus helps mitigate binary risk.

For more information on Oryzon, please visit the Edison website.

< Previous
Next >

You may also be interested in these:

Healthcare

Oryzon Genomics – executive interview

Healthcare

Oryzon Genomics – executive interview
Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.